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To evaluate pulse pressure (PP) changes according to duration of type 1 diabetes mellitus 
(T1DM) and to assess the influence of posture.   
RESEARCH DESIGN AND METHODS 
Continuous measurement of blood pressure with a Finapres® device during a 3x1min posture 
test (standing-squatting-standing) in 159 T1DM patients divided into four groups according to 
diabetes duration (<10 years, 11-20 years, 21-30 years and > 30 years from group 1 to group 
4, respectively) and compared to age-matched nondiabetic subjects.    
RESULTS 
PP progressively increased according to T1DM duration (p<0.0001), especially in 
women, but not in age-matched nondiabetic subjects (NS). PP increase from group 1 to group 
4 was amplified in squatting position (from 50±17 to 69±14 mmHg) compared to standing 
(from 44±15 to 55±12 mmHg). 
 CONCLUSION 
PP increases according to T1DM duration, more in women than in men, and the squatting 
position sensitizes such PP increase in both genders. 
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Early vascular aging was reported in type 1 diabetes (T1DM) (1-5). Arterial pulse 
pressure (PP), a surrogate marker of artery stiffness, is an independent cardiovascular disease 
(CVD) risk factor in T1DM patients (6), as in non-diabetic (7-9) or T2DM (10,11) 
individuals. This cross-sectional controlled study investigated the influence of T1DM 
duration, gender and posture on PP.  
 
RESEARCH DESIGN AND METHODS  
 
Patients 
We evaluated 159 T1DM patients (20-60 years). Subjects were retrospectively separated 
according to diabetes duration into four groups and compared to age-matched healthy controls 
to take into account normal aging (12) (Table 1). 
 
Monitoring of blood pressure 
Systolic and diastolic BP were measured continuously with a FinapresR (FINger Arterial 
PRESsure) instrument (Ohmeda, USA) (13-15) during an orthostatic test (successively 1 min 
standing, 1 min squatting, 1 min standing) (16-18). Means (± SD) of mean blood pressure 
(MBP) and PP (systolic minus diastolic) were calculated throughout the test (overall), during 
initial standing only and in the squatting position.  
 
Statistical analysis 
We performed univariate analysis using ANOVA followed by Student’s t test, with 
two-tailed p values < 0.05 considered as significant. 
 
RESULTS  
MBP remained almost stable across the four diabetic groups while PP progressively 
increased according to T1DM duration (ANOVA p<0.0001; Table 1). There was a marked 
difference in overall PP between groups 1-2 and groups 3-4 (49±14 vs 59±14 mmHg; 
p<0.00002), contrasting with no difference in age-matched controls (mean of 35 years for 
groups 1-2 vs 46 years for groups 3-4: 51±12 vs 50±15 mmHg; NS).  
PP levels were lower in diabetic and non-diabetic women compared to men, except in 
group 4 with T1DM > 30 years (data not shown). The progressive PP increase from TIDM 
group 1 to group 4 was almost double in women (from 44±16 to 63±11 mmHg) than in men 
(from 51±15 to 61±13 mmHg). 
The graduate rise in PP from group 1 to group 4 in T1DM, already present in initial 
standing (from 44 to 55 mmHg), was markedly amplified in squatting (from 50 to 69 mmHg) 
(Table 1).  
 
CONCLUSIONS 
The present study essentially demonstrates: 1) a progressive PP increase according to 
T1DM duration, especially when it exceeds 20 years; 2) an early PP rise in T1DM subjects 
already below the age of 50 years, especially in women; and 3) the amplification of this 
phenomenon by squatting.  
 In the FinnDiane study, PP was higher in diabetic patients of all age categories, 
including in patients below 45 years (5). However, previous observations showed no (19) or 
only marginally increased PP values (< 5 mmHg) in young (25-30 years) T1DM patients 
(2,3,20). A recent study reported an 11 mmHg higher brachial PP and a 8 mmHg higher 
carotid PP in patients with 15.3 years T1DM duration as compared to controls (21). We 
observed markedly PP increase (difference of almost 10 mmHg) in T1DM patients aged > 40 
years with disease duration above 20 years compared to age-matched controls. Multiple 
regression analysis of the FinnDiane study indicates that T1DM duration per se has a 
considerable impact on PP, independent of age and renal involvement (5). PP rises with age, 
more so in women (22). In healthy subjects, PP was higher in men than in women, although 
the difference decreased from <20 years to 40-49 years (12), while in the FinnDiane study 
lower PP levels in nondiabetic females compared to men below the age of 40-45 years tended 
to become higher afterwards. In the diabetic population, an earlier and steeper PP rise 
according to age was shown in women compared to men (5). Increased aortic wall stiffness 
with T1DM was more markedly related to diabetes duration in women than in men (23).  
Squatting increases preload by augmentation of venous return and increases cardiac 
output without changes in systemic vascular resistance (16,17,24), resulting in greater 
increase of systolic than diastolic BP and PP augmentation (15,25). Interestingly, the 
squatting-induced PP rise markedly increased with T1DM duration, being almost doubled in 
patients with >20 years T1DM compared to patients with <20 years T1DM. Both increased 
arterial stiffness and alteration of wave reflection may contribute to the predominant PP 
increase in squatting position with T1DM duration (26). Furthermore, advanced glycation end 
products (AGEs) may profoundly alter the histomorphometric arterial pattern, reducing 
compliance and distensibility, and NO-dependent vascular dilation (27). 
Our study has some limitations. First, the cross-sectional design did not allow 
following patients prospectively. Second, PP was measured at the finger site. However, PP 
changes in radial artery and finger were almost similar during a head-up tilt (28). Finally, 
T1DM patients were not well controlled, precluding any extrapolation to T1DM patients with 
excellent glucose control.  
The Framingham Heart Study showed that PP is an excellent predictor of CHD risk, at 
least in nondiabetic individuals >50 years of age (29). PP was also a major determinant of 
CVD complications in young T1DM individuals of the Eurodiab Prospective Complications 
study (6), in agreement with accelerated vascular aging and earlier arterial stiffening in T1DM 
(1,4,19,21). The greater PP increase in diabetic women according to disease duration (5) may 
contribute to the higher relative (versus age-matched nondiabetic controls)  CVD risk 
compared to diabetic men (30). AGEs were associated with increased PP in T1DM (27), an 
additional argument for intensifying glucose control to reduce CVD risk (31).  
In conclusion, T1DM is associated with a progressive PP increase according to disease 
duration, a finding suggestive of accelerated arterial stiffening that may explain the higher 
CVD risk of T1DM patients, especially in women. The squatting position sensitizes the 
detection of increased PP in diabetic patients and may help detect patients at higher risk. 
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Table 1: Characteristics of the type 1 diabetic patients (D) and nondiabetic subjects (ND) used as controls in the four subgroups divided 
according to diabetes duration and age matching, respectively, and mean blood pressure (MBP) and pulse pressure (PP) levels recorded during 
the whole test (overall), in the initial standing position and in the squatting position. Results are expressed as mean ± SD.  NA : Not applicable. 
  
GROUP 1 
D ≤ 10 years 
GROUP 2 
D 11 – 20 years 
GROUP 3 
D 21 – 30 years 
GROUP 4 
D ≥ 30 years 
P value 
Anova G1-G4 
 D ND D ND D ND D ND D ND 
n 39 30 45 30 57 30 18 28   
Age (yrs) 34 ± 10 33 ± 10 37 ± 10 37 ± 11 45 ± 9 44 ± 11 48 ± 8 48 ± 9 0.0000 0.0000 
Sex ratio 22F/17M 17F/13M 21F/24M 14F/16M 24F/33M 14F/16M 8F/10M 18F/10M   
BMI (kg/m2) 22.6 ± 3.3 23.1 ± 2.8 23.5 ± 2.4 23.6 ± 3.3 24.3 ± 4.4 24.7 ± 4.5 23.1 ± 2.2 24.4 ± 3.7 0.1005 0.3055 
T1DM duration (yrs) 6 ± 3 - 16 ± 3 - 26 ± 3 - 38 ± 8 - 0.0000 NA 
HbA1c (%) 8.92 ± 1.68 - 8.72 ± 1.19 - 8.43 ± 1.25 - 8.85 ± 1.18 - 0.4215 NA 
           
MBP  Overall 80 ± 10 82 ± 11 80 ± 11 80 ± 13 86 ± 12 85 ± 16 80 ± 13 84 ± 14 0.0149 0.1946 
MBP  Standing 79 ± 10 81 ± 10 79 ± 12 79 ± 12 84 ± 12 84 ± 16 77 ± 13 83 ± 16 0.0496 0.1816 
MBP  Squatting 84 ± 13 85 ± 12 87 ± 13 86 ± 15 94 ± 13 90 ± 16 87 ± 14 89 ± 15 0.0000 0.2422 
           
PP Overall 48 ± 16 49 ± 11 52 ± 13 53 ± 13 59 ± 14a 49 ± 14 62 ± 12b 51 ± 15 0.0001 0.3783 
PP Standing 44 ± 15 45 ± 10 47 ± 13 48 ± 12 54 ± 14 46 ± 15 55 ± 12 49 ± 15 0.0004 0.1885 
PP Squatting 50 ± 17 51 ± 13 56 ± 15 55 ± 13 64 ± 16c 51 ± 15 69 ± 14c 52 ± 15 0.0000 0.4851 
a : p<0.05    D vs ND         b : p<0.01    D vs ND          c : p<0.001  D vs ND 
